INCR
InterCure Ltd.
5.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -221.7% | – | – | – | – | – | – | – | +0.0% | -61.9% | +625.4% | – | |
| – | -27.0% | -72.3% | – | – | – | +0.0% | – | – | +0.0% | +2.9% | +0.0% | – | |
| – | -48.5% | -32.6% | -87.7% | – | – | +0.0% | +132.5% | -44.5% | +0.0% | +74.5% | +0.0% | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -214.6% | – | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | -85.3% | -99.4% | -100.0% | – | – | +0.0% | -100.0% | – | +0.0% | -90.6% | +2,234.9% | – | |
| – | +0.0% | – | – | – | – | +0.0% | – | – | +0.0% | – | -270.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -259.9% | – | – | – | – | +0.0% | – | – | +0.0% | -66.1% | +690.1% | – | |
| – | -814.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -238.3% | – | – | – | – | – | – | – | +0.0% | -51.5% | +512.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.